
浏览全部资源
扫码关注微信
河南省中医院,郑州 450000
刘永生,硕士,副主任药师,从事临床药学工作,E-mail:1581094633@163.com
* 张辉果,硕士,主治医师,从事中西医结合儿科呼吸疾病的临床工作,E-mail:2330089913@11.com
收稿日期:2020-01-08,
网络出版日期:2020-04-10,
纸质出版日期:2020-11-05
移动端阅览
刘永生,王金菊,张辉果.沙参麦冬汤加减对阴虚肺热证肺炎支原体肺炎恢复期患者免疫炎症反应的影响[J].中国实验方剂学杂志,2020,26(21):149-154.
LIU Yong-sheng,WAGN Jin-ju,ZHANG Hui-guo.Effect of Addition and Subtraction Therapy of Shashen Maidongtang on Immune Inflammatory Response in Patients with Mycoplasma Pneumoniae Pneumonia and Syndrome of Yin Deficiency and Lung Heat at Convalescent Period[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(21):149-154.
刘永生,王金菊,张辉果.沙参麦冬汤加减对阴虚肺热证肺炎支原体肺炎恢复期患者免疫炎症反应的影响[J].中国实验方剂学杂志,2020,26(21):149-154. DOI: 10.13422/j.cnki.syfjx.20200632.
LIU Yong-sheng,WAGN Jin-ju,ZHANG Hui-guo.Effect of Addition and Subtraction Therapy of Shashen Maidongtang on Immune Inflammatory Response in Patients with Mycoplasma Pneumoniae Pneumonia and Syndrome of Yin Deficiency and Lung Heat at Convalescent Period[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(21):149-154. DOI: 10.13422/j.cnki.syfjx.20200632.
目的
2
观察沙参麦冬汤加减对肺炎支原体肺炎恢复期患者阴虚肺热证的疗效及对免疫炎症反应的调节作用。
方法
2
将148例患者按随机数字表法分为对照组和观察组各74例。研究期间对照组脱落、失访2例,剔除3例完成70例;观察组脱落、失访4例,完成71例。两组患者均口服阿奇霉素片,10 mg·kg
-1
·d
-1
,连服3 d;和匹多莫德颗粒剂,0.4~0.8 g/次,2次/d;和氨溴特罗口服溶液,2.5~15 mL/次,2次/d。对照组口服养阴清肺口服液,5~10 mL/次,2~3次/d;观察组内服沙参麦冬汤加减,1剂/d。两组疗程均为7 d。进行治疗前后咳嗽症状评分和咳嗽视觉模拟评分(VAS);记录咳嗽、肺部湿啰音,咯痰消失时间和胸片复常时间;进行治疗前后阴虚肺热证评分和莱塞斯特咳嗽问卷(LCQ)评分;检测治疗前后T淋巴细胞亚群(CD3
+
,CD4
+
,CD8
+
和CD4
+
/CD8
+
)和白细胞介素-6(IL-6),IL-10,肿瘤坏死因子-
α
(TNF-
α
),P物质(SP),降钙素原基因相关肽(CGRP)水平;进行治疗后安全性评价。
结果
2
观察组疾病疗效总有效为95.77%(68/71),优于对照组的82.86%(58/70)(
χ
2
=6.186,
P<
0.05);观察组患者咳嗽症状积分和VAS评分均明显低于对照组(
P
<
0.01);观察组患者LCQ量表各维度评分和LCQ总分均高于对照组(
P
<
0.01);观察组患者咳嗽、肺部湿啰音、咯痰消失时间及胸片复常时间均短于对照组(
P<
0.01);观察组CD3
+
,CD4
+
,CD4
+
/CD8
+
均高于对照组(
P
<
0.01),CD8
+
低于对照组(
P
<
0.01);观察组血清IL-6,IL-10,TNF-
α
水平和痰液中SP和CGRP水均低于对照组(
P<
0.01)。
结论
2
在西医常规治疗的基础上,采用沙参麦冬汤加减内服治疗MPP恢复期阴虚肺热证患者,可减轻咳嗽程度,缩短病程,改善了生活质量,提高了细胞免疫功能,减轻了炎性损伤,降低了咳嗽敏感性,有较好的临床疗效,且使用安全。
Objective
2
To observe the clinical efficacy of addition and subtraction therapy of Shashen Maidongtang for syndrome of Yin deficiency and lung heat at convalescent period in patients with mycoplasma pneumoniae pneumonia, and to investigate its regulatory effect on immune inflammatory response.
Method
2
One hundred and forty-eight patients were randomly divided into control group (74 cases) and observation group (74 cases) by random number table. During the treatment, 70 patients completed the study in control group (loss to follow-up in 2 cases, elimination in 3 cases), and 71 patients completed the study in observation group (loss to follow-up in 4 cases). Patients in both groups got Azithromycin tablets for 3 days, 10 mg·kg
-1
·d
-1
, pidotimod granules, 0.4-0.8 g/time, 2 times/day, and Ambroxol oral solution, 2.5-15 mL/time, 2 times/day. The patients in control group additionally received Yangyin Qingfei oral liquid, 5-10 mL/time, 2-3 times/day, while the patients in observation group additionally received addition and subtraction therapy of Shashen Maidongtang, 1 dose/day, with a treatment course of 7 days in both groups. Before and after treatment, scores of cough symptom and cough visual analogue score (VAS) were graded, and the time to disappearance of cough, lung rales and expectoration as well as the time to recovery of chest radiograph were recorded. Scores of syndrome of yin deficiency and lung heat and Leicester Cough Questionnaire (LCQ) were also graded. Levels of T lymphocyte subsets (CD3
+
, CD4
+
, CD8
+
and CD4
+
/CD8
+
), interleukin-6 (IL-6), IL-10, tumor necrosis factor-
α
(TNF-
α
), substance P (Substance P) and procalcitonin gene related peptide (CGRP) were detected, and the safety was also evaluated.
Result
2
Total effective rate for the disease was 95.77% (68/71) in observation group, higher than 82.86% (58/70) in control group (
χ
2
=6.186,
P<
0.05). Scores of cough symptoms and VAS were higher than those in control group (
P<
0.01), and scores of various items in LCQ scale and the total score of LCQ were all higher than those in control group (
P<
0.01). The time to disappearance of cough, lung rales and expectoration as well as the time to recovery of chest radiograph in observation group were shorter than those in control group (
P<
0.01). Levels of CD3
+
, CD4
+
and CD4
+
/CD8
+
were higher than those in control group (
P<
0.01), and levels of CD8
+
, IL-6, IL-10, TNF-
α
, SP in serum and CGRP in sputum were all lower than those in control group (
P<
0.01).
Conclusion
2
On the basis of conventional western medicine treatment, addition and subtraction therapy of Shashen Maidongtang can reduce the degree of cough, shorten the course of disease, improve the quality of life, improve the cellular immune function, reduce the inflammatory injury, and reduce the sensitivity of cough, with better clinical efficacy and safety as compared with Western medicine alone.
儿童社区获得性肺炎诊疗规范( 2019 年 版)编写审定专家组.儿童社区获得性肺炎诊疗规范(2019年版) [J]. 全科医学临床与教育, 2019 , 17 ( 9 ): 771 - 777 .
中华中医药学会儿童肺炎联盟 . 儿童肺炎支原体肺炎中西医结合诊治专家共识(2017年制定) [J]. 中国实用儿科杂志 , 2017 , 32 ( 12 ): 881 - 885 .
张晓娟 , 沈伊娜 . 小儿肺炎支原体肺炎发病机制的研究进展 [J]. 安徽医学 , 2016 , 37 ( 1 ): 111 - 113 .
谭丹 , 姜之炎 . 中医药治疗儿童肺炎支原体肺炎的机制研究进展 [J]. 中华中医药学刊 , 2018 , 36 ( 6 ): 1403 - 1406 .
武晓群 , 马健 , 易兵 , 等 . 沙参麦冬汤临床及实验研究进展 [J]. 江苏中医药 , 2012 , 44 ( 3 ): 75 - 76 .
史晓霞 . 小儿肺炎支原体肺炎恢复期气道高反应的中医治疗 [J]. 浙江中医药大学学报 , 2011 , 35 ( 2 ): 155 - 156 .
中华医学会儿科学分会呼吸学组 . 儿童社区获得性肺炎管理指南(2013修订)(上) [J]. 中华儿科杂志 , 2013 , 51 ( 10 ): 745 - 752 .
中华医学会呼吸病学分会哮喘学组 . 咳嗽的诊断与治疗指南(2015) [J]. 中华结核和呼吸杂志 , 2016 , 39 ( 5 ): 323 - 354 .
刘孟书 , 胡思源 , 贺爱燕 . 中药治疗儿童支原体肺炎临床试验设计述要 [J]. 药物评价研究 , 2018 , 41 ( 4 ): 508 - 512 .
FRENCH C T , IRWIN R S , FLETCHER K E , et al . Evaluation of a cough-specific quality-of-life questionnaire [J]. Chest , 2002 , 121 ( 4 ): 1123 - 1131 .
吴倩 , 吴起武 . 儿童肺炎支原体感染流行病学的研究进展 [J]. 中国妇幼保健 , 2016 , 31 ( 5 ): 1111 - 1114 .
王雪峰 , 张秀英 . 从风温伏肺论治儿童肺炎支原体肺炎 [J]. 世界科学技术—中医药现代化 , 2017 , 19 ( 11 ): 1878 - 1881 .
荣毅 , 王蕾 , 刘志国 , 等 . 益气养阴、清热活血法治疗小儿重症肺炎支原体肺炎合并肺不张 [J]. 中医杂志 , 2018 , 59 ( 16 ): 1426 - 1428 .
杨香红 , 李艳莉 , 罗春玉 . 肺炎支原体肺炎患儿免疫功能的变化及其与病情程度和疾病分期的关系 [J]. 实用临床医药杂志 , 2016 , 20 ( 7 ): 113 - 116 .
黎素清 . 肺炎支原体感染后机体的体液免疫、外周血T淋巴细胞亚群含量的评估 [J]. 海南医学院学报 , 2017 , 23 ( 3 ): 339 - 341 .
张会敏 , 马宏 . 肺炎支原体致病机制的研究进展 [J]. 中国现代医生 , 2015 , 53 ( 19 ): 157 - 160 .
周晓飞 , 过毅 . 儿童难治性肺炎支原体肺炎血清中IL-6,IL-10及免疫功能的变化及临床意义 [J]. 中国优生与遗传杂志 , 2019 , 27 ( 10 ): 1270 - 1272 .
LUKACS N W , SMIT J J , MUKHERJEE S , et al . Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation [J]. J Immunol , 2010 , 185 ( 4 ): 2231 - 2239 .
0
浏览量
16
下载量
4
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621